Clinical Trials

How to Avoid Significant Delays in Multi-country Studies Due to EU 536/2014 Clinical Trial Regulation

January 27, 2022

NASH Populations with Cirrhosis: Drug Development Challenges and Solutions

February 16, 2022

Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program

November 05, 2021
Blogs

How the Approval of Aducanumab Will Change Alzheimer’s Trials — Xtalks Life Science Podcast Ep. 25
Blogs

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials
Blogs

AAIC 2021: Best Practices for Remote Cognitive Assessments for Alzheimer’s Patients During COVID-19

AI and Cloud – Power of Modern Trial Infrastructure for Accelerated Drug Development

May 21, 2021

Cardiovascular event adjudication during COVID-19 and Beyond

May 21, 2021
Blogs

Clinical Research Jobs: How to Choose the Right Career Path
Blogs

Why Every Organization Needs a Clinical Data Strategy
Blogs

New White Paper on Advanced Therapies Sets up Developers for Success
Blogs

Diseases Don’t Discriminate, So Why Aren’t Clinical Trials More Diverse?
Blogs

Rare Disease Clinical Research: Strategies for Ensuring Endpoint Integrity

The Transformation of Clinical Trial Design & Operations – A Panel Discussion on COVID-19 as a Catalyst for Decentralized Trials

September 01, 2020

Addressing the Recent ISO 21973 Guidance: Considerations for Cell and Gene Therapy Distribution

October 01, 2020
Blogs

Considerations for the Next Wave of COVID-19 Development